The Federation of European Neuroscience Societies (FENS) has responded to the recent European Parliament’s Intergroup on the Welfare and Conservation of Animals statement on the use of animals in neuroscience, which claimed that, ‘Animal testing is inherently uncertain and is a misleading indicator for human trials’.
In its own response statement FENS said: ‘The value of animal-based research for wide-reaching scientific and medical advances, including in neuroscience, cannot be overstated.’
The statement, also backed by EARA, EFPIA, GIRCOR, RSB, TVV and Wellcome, continued: ‘While there is an element of uncertainty in drug-related R&D, the use of animals in neuroscience research has undoubtedly contributed to our ever-improving understanding of the human brain and important advances in the treatment of neurological diseases.’
The European Directive 2010/63 that protects animals required for scientific purposes was enforced in Member states in 2012. The Directive introduced the 3R principles of replacement, reduction and refinement of animal procedures into regulation. The scientific community has recognised the Directive as the world’s most progressive and stringent framework seeking to ensure high animal welfare standards while encouraging the development of alternative methods. As a result of this new legislation, there has been a growing interest in the development and implementation of alternative methods. One initiative pursuing this goal is the European Partnership for Alternative Approaches to Animal Testing (EPAA). Continue reading →